Why the study?
Do sirolimus-eluting stents improve outcomes compared with bare metal stents in coronary bifurcation lesions?
Do sirolimus-eluting stents improve outcomes compared with bare metal stents in coronary bifurcation lesions?
Sirolimus-eluting stents offer improvement over bare metal stents for coronary bifurcation lesions, but side branch restenosis remains a challenge.
Answers are grounded in this paper and cite their sources.
Sirolimus-eluting stents merit randomized trials in bifurcations; observational data should not yet change practice.
These results are an improvement compared with historical controls using bare metal stents. Restenosis at the SB remains a problem. At this time, no statement can be made regarding the most appropriate technique to use when treating bifurcations with the Cypher stent.
No takes yet. Share an insight, caveat, or question.
Colombo et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: